Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-08-15FDA Approved: ALOGLIPTIN AND PIOGLITAZONE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for the alogliptin and pioglitazone combination product, manufactured by Padagis Israel Pharmaceutic…
-
CLINICAL_TRIALS trial_result · 2013-08-15Clinical Trial Update: The Effect of Welchol on Glucose Metabolism in Type 2 Diabetics [Phase 4]
Phase 4 study evaluating the effect of Welchol on glucose metabolism in adults with Type 2 diabetes has completed, with results posted in 20…
-
FDA approval · 2013-08-14FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for Lantus SoloStar (insulin glargine) from Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2013-08-14Clinical Trial Update: Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus
This completed clinical trial reports characterization of the variability of insulin secretory parameters during meal tolerance and maximal …
-
CLINICAL_TRIALS trial_result · 2013-08-13Clinical Trial Update: Effects of 5-day Statin Withdrawal on Endothelial Progenitor Cells and Inflammatory Markers in Type 2 Diabetic Patients [Phase 4]
Phase 4 trial evaluating the effects of a 5-day withdrawal of statin therapy on endothelial progenitor cells and inflammatory markers in pat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-08-06Clinical Trial Update: Study Of Safety And Efficacy Of PF-04991532 In Subjects With Type 2 Diabetes Mellitus [Phase 2]
Pfizer completed a Phase 2 trial evaluating the safety and efficacy of PF-04991532 in adults with Type 2 diabetes mellitus. Results were pos…
-
CLINICAL_TRIALS trial_result · 2013-08-05Clinical Trial Update: A Clinical Trial to Study the Efficacy, Safety, Tolerability and Pharmacokinetics of P2202 in Patients of Type 2 Diabetes [Phase 2]
A Phase 2 clinical trial evaluating P2202 for Type 2 Diabetes Mellitus sponsored by Piramal Enterprises Limited has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Diabetes Connect: Patients and Providers Use of a Secure Website for Blood Glucose Monitoring in Type-2 Diabetes [NA]
The Diabetes Connect trial evaluating a secure website for blood glucose monitoring in type 2 diabetes has completed.
-
CLINICAL_TRIALS other · 2013-08-02Clinical Trial Update: Liraglutide and Insulin Therapy in Patients With Type 2 Diabetes [NA]
An update on a clinical trial evaluating liraglutide in combination with insulin therapy for people with type 2 diabetes. The current status…
-
CLINICAL_TRIALS trial_result · 2013-08-01Clinical Trial Update: Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus [Phase 2]
Phase 2 safety and efficacy study of JTT-851 in patients with Type 2 Diabetes Mellitus has been completed.
-
FDA approval · 2013-07-31FDA Approved: BROMOCRIPTINE MESYLATE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' supplemental application for Bromocriptine Mesylate, resulting in updated labeling for the product.
-
CLINICAL_TRIALS trial_result · 2013-07-31Clinical Trial Update: Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin [Phase 3]
A Phase 3 trial comparing AC2993 with insulin glargine in patients with Type 2 diabetes who also use a sulfonylurea and metformin; results h…
-
CLINICAL_TRIALS trial_result · 2013-07-31Clinical Trial Update: Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin [Phase 3]
Phase 3 trial comparing exenatide with twice-daily biphasic insulin aspart in adults with Type 2 diabetes mellitus on sulfonylurea and metfo…
-
CLINICAL_TRIALS research · 2013-07-31Clinical Trial Update: Metformin Use and Vitamin B12 Deficiency
This clinical trial update discusses metformin use and its potential association with vitamin B12 deficiency in people with type 2 diabetes …
-
FDA approval · 2013-07-30FDA Approved: NATEGLINIDE — Supplemental Application (Strides Pharma Science Limited)
The FDA approves a supplemental application for Nateglinide by Strides Pharma Science Limited.
-
CLINICAL_TRIALS trial_result · 2013-07-30Clinical Trial Update: The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial) [Phase 3]
Phase 3 trial comparing canagliflozin to a DPP-4 inhibitor in type 2 diabetes has completed with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-07-30Clinical Trial Update: Patient Preference and Satisfaction With Insulin Glargine (Lantus) Solostar Pen vs Conventional Vial-Syringe Method of Lantus Injection Therapy in Patients With Type 2 Diabetes Mellitus [Phase 4]
Phase 4 trial comparing patient preference and satisfaction of Lantus insulin glargine delivered by Solostar Pen versus vial-syringe injecti…
-
CLINICAL_TRIALS trial_result · 2013-07-30Clinical Trial Update: Additional GLP-1 Analogue on CSII Treatment for Poorly Controlled Type 2 Diabetic Patients [NA]
A completed clinical trial evaluating an additional GLP-1 analogue for patients with poorly controlled type 2 diabetes on continuous subcuta…
-
FDA approval · 2013-07-26FDA Approved: GLIPIZIDE — Supplemental Application (Apotex Corp.)
FDA approved Apotex Corp.'s supplemental application for Glipizide (generic) under an Abbreviated New Drug Application (ANDA).
-
FDA approval · 2013-07-26FDA Approved: GLIPIZIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for glipizide submitted by Actavis Pharma, Inc., extending the existing approval.
-
CLINICAL_TRIALS trial_result · 2013-07-26Clinical Trial Update: Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D) [Phase 2, Phase 3]
Clinical trials evaluating SALsalate targeting inflammation in type 2 diabetes have completed Phase 2 and Phase 3 with results posted.
-
EMA research · 2013-07-26Investigation into GLP-1-based diabetes therapies concluded
EMA investigation into GLP-1-based diabetes therapies has concluded, summarizing findings without additional regulatory action.
-
CLINICAL_TRIALS research · 2013-07-25Clinical Trial Update: Management of Albuminuria in Hypertensive Diabetics
Clinical trial update on managing albuminuria in hypertensive patients with type 2 diabetes; no results or status details are provided.
-
CLINICAL_TRIALS trial_result · 2013-07-24Clinical Trial Update: Pilot Study of the Effects of Erythritol on Endothelial Function in Patients With Type 2 Diabetes Mellitus [NA]
A pilot clinical trial assessed the effects of erythritol on endothelial function in patients with type 2 diabetes and has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-23Clinical Trial Update: Effects of Legume Intake on Cardiovascular Risk Factors Among Adults at Risk for Diabetes [NA]
A completed study investigated whether increasing legume intake influences cardiovascular risk factors in adults at risk for Type 2 diabetes…